Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -45.36M
March 31, 2026 -41.80M
December 31, 2025 -43.68M
September 30, 2025 -34.73M
June 30, 2025 -37.66M
March 31, 2025 24.39M
December 31, 2024 18.30M
September 30, 2024 59.64M
June 30, 2024 49.08M
March 31, 2024 -21.41M
December 31, 2023 -26.23M
September 30, 2023 -67.39M
June 30, 2023 -76.45M
March 31, 2023 -81.40M
December 31, 2022 -90.02M
September 30, 2022 -110.08M
June 30, 2022 -119.60M
March 31, 2022 -112.75M
December 31, 2021 -124.66M
September 30, 2021 -154.66M
Date Value
June 30, 2021 -150.54M
March 31, 2021 -169.17M
December 31, 2020 -126.52M
September 30, 2020 -80.18M
June 30, 2020 -76.34M
March 31, 2020 -64.38M
December 31, 2019 -82.10M
September 30, 2019 -99.47M
June 30, 2019 -87.60M
March 31, 2019 -76.45M
December 31, 2018 -72.85M
September 30, 2018 -59.94M
June 30, 2018 -60.00M
March 31, 2018 -57.67M
December 31, 2017 -54.98M
September 30, 2017 -39.10M
June 30, 2017 -32.39M
March 31, 2017 -35.46M
December 31, 2016 -46.73M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
DBV Technologies SA -152.18M
Akari Therapeutics Plc -10.74M
EDAP TMS SA --
Bicycle Therapeutics Plc -207.47M
argenx SE 1.090B